GoodRx Holdings, Inc. - GDRX STOCK NEWS

CVS Caremark and GoodRx have launched Caremark Cost Saver, a prescription drug discount solution aimed at lowering pharmacy out-of-pocket costs for CVS Caremark clients' members. The program provides automatic access to GoodRx's prescription pricing, allowing members to pay lower prices on generic medications. The amount paid will be applied to plan members' deductible and out-of-pocket thresholds. No action is required by the plan member.

GoodRx appoints Dorothy Gemmell as Chief Commercial Officer to co-lead Pharma Manufacturer Solutions business and oversee GoodRx Health and Provider Mode. Gemmell brings extensive industry experience and will focus on expanding brand partnerships and scaling GoodRx's solutions for medication adherence.

GoodRx Holdings, Inc. (Nasdaq: GDRX) will be presenting at the Jefferies Healthcare Conference on June 8, 2023. The presentation will be available via live webcast and archived recording on the Company's Investor Relations website.

GoodRx Holdings, Inc. (NASDAQ: GDRX) has appointed Scott Wagner, former CEO of GoDaddy, as its Interim CEO, effective April 25, 2023. Co-founders Doug Hirsch and Trevor Bezdek will transition to roles as Chief Mission Officer and Chairman, respectively. Wagner brings over 25 years of experience and aims to enhance product innovation and customer base growth. With his leadership, GoodRx aims to improve healthcare accessibility and affordability, having helped Americans save over $55 billion on medications. Hirsch will continue to focus on operationalizing the company's mission, while Bezdek will guide healthcare strategy and innovation. An update for investors is anticipated during the earnings call on May 10.

GoodRx Holdings, Inc. (GDRX) will release its Q1 2023 financial results before U.S. markets open on May 10, 2023. A conference call is scheduled for 5:00 a.m. Pacific Time to discuss the results and business outlook. GoodRx, a leading digital healthcare platform, provides consumers with access to lower prices for medications and telehealth consultations. Since its inception in 2011, GoodRx has helped individuals save over $55 billion on healthcare costs. The earnings call will be accessible online, and an archived version will be available for 30 days post-call.

GoodRx Holdings, Inc. (Nasdaq: GDRX) reported its fourth quarter and full-year 2022 financial results, exceeding previous guidance. Q4 2022 revenue was $184.1 million, a 14% decline year-over-year, with a net loss of $2.01 million. Adjusted net income for Q4 stood at $27.4 million. Annual revenue was $766.6 million with a net loss of $32.81 million. Prescription transactions revenue fell 19% due to an 8% drop in Monthly Active Consumers and continued grocer-related issues, estimated to impact revenue by $40-$50 million. Future guidance for Q1 2023 projects revenue of $181-$183 million, reflecting ongoing challenges.

GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, will present at the Cowen 43rd Annual Health Care Conference in Boston, MA, on Tuesday, March 7, 2023, at 6:50 a.m. Pacific Time (9:50 a.m. Eastern Time). A live webcast of the presentation can be accessed through the Company’s investor relations website at https://investors.goodrx.com/, with an archived recording to be available for 30 days afterward. GoodRx has been committed to making healthcare affordable, saving consumers over $45 billion since 2011, and remains one of the most downloaded medical apps in the past decade.